Carisoprodol Tablet
Product Images NDC 71610-761

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 71610-761). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 350 mg (71610 0761 30)

Label for Carisoprodol USP 350 mg oral tablets, packaging contains 30 tablets. The label includes storage instructions, manufacturer Aphena Pharma Solutions - Tennessee, LLC, and highlights the prescription status and controlled substance classification (C-IV). Additional details include NDC 71610-0761-30 and batch and expiration information.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Structural Formula (Structure)

Chemical structure of Carisoprodol, showing its molecular configuration with functional groups and carbon chains as depicted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.